Drug intelligence / Profile preview

ipalat Hydro Med

Development stage: Unknown
Lead developer: Dr. Pfleger
Modality: Small Molecules
Administration: Oral

Overview

ipalat Hydro Med is a non-prescription mucoadhesive lozenge classified as a medical device, developed by Dr. Pfleger Arzneimittel GmbH for the relief of oropharyngeal symptoms such as sore throat, hoarseness, and dry mouth. The product utilizes a "Hydro Effect" mechanism, where its active complex—comprising gum arabic, hydroxyethyl cellulose, sodium hyaluronate, and carrageenan—stimulates salivation and forms a protective, moisture-binding gel film over the oral and pharyngeal mucosa. This physical barrier soothes irritation and shields the membranes from further external irritants. It is sugar-free and contains natural flavorings from primrose root, star anise, and fennel.

Brand names: ipalat Hydro Medipalat Hydro Med akut
Other names: ipalat Hydro Med lozenges

Beyond the preview

Go deeper on ipalat Hydro Med.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ipalat Hydro Med.

Explore the full profile